Revolution Medicines (RVMD) Net Margin (2019 - 2023)
Revolution Medicines' quarterly Net Margin came in at 21770.49% in Q4 2023, down 2140175.0% year-on-year from N/an in Q4 2022, and down 746.92% quarter-over-quarter from 2570.55% in Q2 2023.
Revolution Medicines has reported Net Margin for 5 years, with the latest figure at 21770.49% in Q4 2023.
- For the quarter ending Q4 2023, Net Margin fell 2140175.0% year-over-year to 21770.49%; the trailing twelve-month figure through Sep 2024 stood at 76423.32% (down 7515705.0% YoY), and the FY2023 full-year result was 3768.28%, down 306533.0% from the prior year.
- Net Margin for Q4 2023 stood at 21770.49%, down from 2570.55% in the prior quarter.
- The five-year high for Net Margin was 97.27% in Q1 2019, with the low at 21770.49% in Q4 2023.
- Average Net Margin over 5 years is 1952.74%, with a median of 390.86% recorded in 2020.
- Year-over-year, Net Margin soared 262334 bps in 2022 and sank 2140175 bps in 2023.
- Tracing RVMD's Net Margin over 5 years: stood at 155.91% in 2019, then sank by 151 bps to 390.86% in 2020, then tumbled by 42 bps to 556.83% in 2021, then jumped by 34 bps to 368.73% in 2022, then plunged by 5804 bps to 21770.49% in 2023.
- The last three Net Margin figures came in at 21770.49% (Q4 2023), 2570.55% (Q2 2023), and 970.89% (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -21,770.49% |
| Jun 30, 2023 | -2,570.55% |
| Mar 31, 2023 | -970.89% |
| Dec 31, 2022 | -368.73% |
| Sep 30, 2022 | -2,185.01% |
| Jun 30, 2022 | -671.59% |
| Mar 31, 2022 | -760.72% |
| Dec 31, 2021 | -556.83% |
| Sep 30, 2021 | -4,808.36% |
| Jun 30, 2021 | -509.30% |
| Mar 31, 2021 | -366.95% |
| Dec 31, 2020 | -390.86% |
| Sep 30, 2020 | -215.00% |
| Jun 30, 2020 | -271.47% |
| Mar 31, 2020 | -188.27% |
| Dec 31, 2019 | -155.91% |
| Sep 30, 2019 | -136.45% |
| Jun 30, 2019 | -107.34% |
| Mar 31, 2019 | -97.27% |